J&J Cancer Drug Zytiga Has New Competition
New study results for prostate cancer drug Xtandi showed that the drug prolonged lives and delayed tumor progression when used before chemotherapy.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Chemotherapy | Pharmaceuticals | Prostate Cancer | Study